Physician profile
Grant Allbritten
NPI 1881273472
$1,959.55
in general payments reported to CMS, 2019-2025
7 companies · $1,943 in 2025
The $1,943 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $16.13 · 2025: $1,943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012 · Travel and Lodging: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.64 |
| Travel and Lodging | $947.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,247.95 | 2025 | Accolade Sr |
| Abbvie INC. | $371.99 | 2025 | |
| Abbott Laboratories | $191.41 | 2025 | Eterna, Proclaim |
| Pacira Pharmaceuticals Incorporated | $101.57 | 2025 | Iovera |
| Depuy Synthes Sales INC. | $16.76 | 2025 | Confidence Spinal Cement System |
| Ipsen Biopharmaceuticals, INC | $16.13 | 2024 | Dysport |
| Medtronic, INC. | $13.74 | 2025 | Inceptiv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Allbritten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.